Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

95 results about "Bone remodeling" patented technology

Bone remodeling (or bone metabolism) is a lifelong process where mature bone tissue is removed from the skeleton (a process called bone resorption) and new bone tissue is formed (a process called ossification or new bone formation). These processes also control the reshaping or replacement of bone following injuries like fractures but also micro-damage, which occurs during normal activity. Remodeling responds also to functional demands of the mechanical loading.

Orthodontic Appliance

InactiveUS20090061379A1Effective applicationEasily and safely continuedArch wiresDental toolsBone remodelingTreatment period
The present invention concerns an orthodontic appliance for accelerating the tooth aligning effect and shortening the treatment period, and has an object to provide an appliance which can bring about higher aligning effect than usual ways by giving vibration to tooth to be aligned to activate bone remodeling of the targeted tooth and the alveolar bone and enhance the shift of the tooth. This appliance includes a vibrating element and a dental mouthpiece having the vibrating element built therein. The provision of the vibrating element in the dental mouthpiece facilitates the application of vibration and handling, and continues the treatment safely even at home. The inner shape of the dental mouthpiece serves aligning treatment as well as acceleration of the effect.
Owner:PHC HLDG CORP

Orthodontic appliance

The present invention aims to provide an orthodontic appliance capable of aligning teeth within a shorter period of time than usual without using braces including an orthodontic wire and brackets. This appliance is provided with a dental mouthpiece mountable on teeth and a vibrating element. The dental mouthpiece is so shaped as to apply a biasing force in an aligning direction to a tooth to be aligned in the teeth while being mounted on the teeth. The vibrating element is attached to the dental mouthpiece, generates mechanical vibration and applies the vibration to the tooth to be aligned, thereby activating the bone remodeling of a target tooth and an alveolar bone to promote an orthodontic effect.
Owner:PANASONIC HEALTHCARE HLDG CO LTD

Method for promoting bone growth

A method for treating a patient to promote bone growth, comprising: administering to the patient a therapeutic amount of a bone remodeling agent effective to stimulate bone growth, and a dietary supplement comprising calcium and phosphorus, in a therapeutic amount effective to prevent a deficiency in the amount of calcium or phosphorus available for bone growth.
Owner:RHONDIA INC

Bone remodeling genes

The invention provides polynucleotides and polypeptides that are co-expressed with genes known to be involved in bone remodeling and osteoporosis. The invention also provides expression vectors, host cells, and methods for making a polypeptide, for screening or purifying ligands, and for diagnosing disorders associated with bone remodeling or osteoporosis.
Owner:INCYTE

Methods and apparatuses useful for regulating bone remodeling or tooth movement using light therapy, a functional appliance, and/or vitamin d

Methods are provided for regulating bone remodeling or tooth movement, comprising allowing a functional appliance to exert a force on oral or maxillofacial bone, muscle, or soft tissue, or one or more teeth of a patient in need thereof; and administering an effective amount of light to the oral or maxillofacial bone, muscle, or soft tissue, or one or more teeth, wherein the light is administered before, during, or after the force is exerted. Methods are also provided for regulating bone remodeling, comprising administering an effective amount of vitamin D to an oral or maxillofacial bone, muscle, or soft tissue, or to one or more teeth of a patient in need thereof; and administering an effective amount of light to the oral or maxillofacial bone, muscle, or soft tissue, or to the one or more teeth. Apparatuses useful for providing light therapy and / or vitamin D is also provided.
Owner:BIOLUX RES HLDG INC +1

Polynucleotides and polypeptide sequences involved in the process of bone remodeling

This invention relates, in part, to unique and newly identified genetic polynucleotides involved in the process of bone remodeling; variants and derivatives of the polynucleotides and corresponding polypeptides; uses of the polynucleotides, polypeptides, variants and derivatives; and methods and compositions for the amelioration of symptoms caused by bone remodeling disorders. Disclosed in particular are, the isolation and identification of polynucleotides, polypeptides, variants and derivatives involved in osteoclast activity, validation of the identified polynucleotides for their potential as therapeutic targets and use of the polynucleotides, polypeptides, variants and derivatives for the amelioration of disease states and research purposes.
Owner:DAIICHI SANKYO CO LTD

Dynamic axial nail for intramedullary treatment of long bone fractures

An intramedullary nail for fixation and stabilization of a fractured bone that also allows for a controlled amount of longitudinal motion at the fracture site to encourage bone remodeling and healing is described. The intramedullary nail has a proximal portion and a distal portion that are coupled together in a manner by a biasing assembly that provides for a controlled movement of the proximal and distal portions relative to each other so that when a patient puts pressure on the bone, such as when walking, the fracture site compresses and the bone ends move together, and when the pressure is released from the bone, the bone ends are biased apart by a controlled amount.
Owner:ZIRAN NAVID

Polynucleotides and polypeptide sequences involved in the process of bone remodeling

ActiveUS7989160B2Inhibit and prevent and low differentiationImprove biological activityPeptide/protein ingredientsAntipyreticNucleotideBone remodeling
This invention relates, in part, to unique and newly identified genetic polynucleotides involved in the process of bone remodeling, variants and derivatives of the polynucleotides and corresponding polypeptides, uses of the polynucleotides, polypeptides, variants and derivatives, and methods and compositions for the amelioration of symptoms caused by bone remodeling disorders. Disclosed in particular are the isolation and identification of polynucleotides polypeptides variants and derivatives involved in osteoclast activity, validation of the identified polynucleotides for their potential as therapeutic targets and use of the polynucleotides, polypeptides, variants and derivatives for the amelioration of disease states and research purposes.
Owner:DAIICHI SANKYO CO LTD

Preparation method and use of medical metal artificial bone trabecula

The invention discloses a metal artificial bone trabecula for medical purposes. The structural design of the metal artificial bone trabecula is completed by a computer, and then inputted in an electron beam fusion former; the high temperature generated by electron beams is used to carry out the stratified scanning and high-temperature fusion to titanium alloy powder in the former so as to obtain the metal artificial bone trabecula with bio-cancellous bone morphology, strength and elasticity modulus and a rough and loose outer surface formed by a porous structure. The obtained artificial bone trabecula has mechanical and biological characteristics similar to a human bone, high surface friction coefficient, stable structure and wide range of application, and is applicable to various bone defects, bone filling, bone supporting, bone remodeling and bone repair in a human skeletal system as well as bone restoration of bone remodeling and substitute bone of different bone joints of a human body.
Owner:TIANXINFU (BEIJING) MEDICAL APPLIANCE CO LTD

Biomaterial composite composition and method of use

This invention relates to a process to facilitate osteochondral bone remodeling in a subject by inducing regeneration of this bone to a healthy, vascularized state capable of supporting the underlying hyaline cartilage of articular joints and spinal discs, both biomechanically and metabolically and to deliver a bioactive agent. This process involves the steps of: administering an effective amount of an injectable in situ curing biomaterial composite to a site. The biomaterial composite product is prepared by a process involving the steps: admixing an alginate solution with a nonporous aggregate of β-tricalcium phosphate, in a sufficient amount to initiate polymerization of the alginate solution, to form a hydrogel having from between 10 to 20 percent by volume of β-tricalcium phosphate.
Owner:UNIVERSITY OF MEMPHIS RESEARCH FOUNDATION

Pharmaceutical compositions and preparations for treatment of metabolic bone disease

The present invention relates to a pharmaceutical composition for the treatment of metabolic bone disease and the method of preparation thereof, and more particularly, to an improved pharmaceutical composition for the therapeutic treatment of metabolic disease and the method of preparation thereof, wherein said composition is prepared as a composite pharmaceutical agent which comprises calcitriol; which reduces the rate of spine fractures and increases bone density; alendronate, a bone resorption inhibitor, as two main active ingredients in an optimal mixing ratio to exert the greatest synergistic therapeutic effect; and adequate amount of other additives such as a resorption fortifier of alendronate. Thereof, the pharmaceutical composition according to the present invention can inhibit hypercalcemia caused when administered by calcitriol alone, compensate the inhibitory activity of bone remodeling caused by alendronate due to the presence of calcitriol, and improve drug compliance associated with the usual difficulty in administration as well as a side effect in esophagus, thus effectively preventing the occurence of osteoporosis.
Owner:YUYU IND

Inhibitors of kinase activity

The present invention relates to pyridines or pyrazines that inhibit kinases. In particular the compounds of the invention inhibit members of the class III PTK receptor family such as FMS (CSF-IR), c-KIT, PDGFRβ, PDGFRα or FLT3 and KDR, SRC, EphA2, EphA3, EphA8, FLT1, FLT4, HCK, LCK, PTK5 (FRK), SYK, DDR1 and DDR2 and RET. The compounds of the invention are useful in the treatment of kinase associated diseases such as immunological and inflammatory diseases; hyperproliferative diseases including cancer and diseases involving neo-angiogenesis; renal and kidney diseases; bone remodeling diseases; metabolic diseases; and vascular diseases.
Owner:YM BIOSCI AUSTRALIA

Methods of impairing osteoclast differentiation using antibodies that bind siglec-15

This invention relates, in part, to unique and newly identified genetic polynucleotides involved in the process of bone remodeling; variants and derivatives of the polynucleotides and corresponding polypeptides; uses of the polynucleotides, polypeptides, variants and derivatives; and methods and compositions for the amelioration of symptoms caused by bone remodeling disorders. Disclosed in particular are, the isolation and identification of polynucleotides, polypeptides, variants and derivatives involved in osteoclast activity, validation of the identified polynucleotides for their potential as therapeutic targets and use of the polynucleotides, polypeptides, variants and derivatives for the amelioration of disease states and research purposes.
Owner:DAIICHI SANKYO CO LTD

Polynucleotides and polypeptide sequences involved in the process of bone remodeling

This invention relates, in part, to unique and newly identified genetic polynucleotides involved in the process of bone remodeling, variants and derivatives of the polynucleotides and corresponding polypeptides, uses of the polynucleotides, polypeptides, variants and derivatives, and methods and compositions for the amelioration of symptoms caused by bone remodeling disorders. Disclosed in particular are the isolation and identification of polynucleotides polypeptides variants and derivatives involved in osteoclast activity, validation of the identified polynucleotides for their potential as therapeutic targets and use of the polynucleotides, polypeptides, variants and derivatives for the amelioration of disease states and research purposes.
Owner:DAIICHI SANKYO CO LTD

Method to enhance orthodontic tooth movement

A method and apparatus to improve and accelerate orthodontic tooth movement and alveolar bone apposition and resorption, constituted of a device providing biocompatible contact anode in contact with gingival epithelia at the area of osteoclastic activity, and biocompatible contact cathode in contact with gingival epithelia at the area of osteoblastic activity, arranged to apply electric current across the anode and the cathode to stimulate alveolar bone remodeling. The method and apparatus provide for an electronic circuit that is pre-programmed via wireless communication to adjust the electric current magnitude and time duration so as to enhance tooth movement, oseteogenesis, and osteoclasia.
Owner:RAPID ORTHODONTICS

Mineralized collagen/high molecule composite porous bone material and preparation method thereof

The invention relates to a mineralized collagen / high molecule composite porous bone material and a preparation method thereof. The preparation method comprises the following steps that a collagen solution is prepared; a calcium-ion-containing aqueous solution is added; a phosphate-radical-ion-containing aqueous solution is added; the pH value is adjusted to be 8; a precipitate is washed, and suction filtration is conducted; freeze-drying is conducted; through grinding, dry mineralized collagen powder is prepared; a high molecule polymer solution is prepared; a polymer / calcium phosphate salt / collagen mixed solution is prepared; freeze-drying is conducted; ultrasonic suction and drying are conducted; sterilization is conducted, and accordingly the mineralized collagen-high molecule compositeporous bone material is prepared. The preparation method has the advantages of being low in cost, high in material utilization rate, easy to implement and the like, and the mineralized collagen-highmolecule composite porous bone material prepared through the method has the advantages of being high in homogeneity and mechanical strength, long in degradation time, low in organic solvent residue content, high in porosity, good in biocompatibility, capable of achieving cooperation of degradation time and bone remodeling and the like.
Owner:BEIJING ALLGENS MEDICAL SCI & TECH

Orthodontic appliance

InactiveUS20100068670A1Easily and safely continuedArch wiresDental toolsBone remodelingTreatment period
The present invention concerns an orthodontic appliance for accelerating the tooth aligning effect and shortening the treatment period, and has an object to provide an appliance which can bring about higher aligning effect than usual ways by giving vibration to tooth to be aligned to activate bone remodeling of the targeted tooth and the alveolar bone and enhance the shift of the tooth. This appliance includes a vibrating element and a dental mouthpiece having the vibrating element built therein. The provision of the vibrating element in the dental mouthpiece facilitates the application of vibration and handling, and continues the treatment safely even at home. The inner shape of the dental mouthpiece serves aligning treatment as well as acceleration of the effect.
Owner:PHC HLDG CORP

Inhibitors of trka kinase

The present invention is directed to the compounds of Formula I which are inhibitors of tropomyosin-related kinase A (TrkA): Formula (I) or steroisomers, tautomers or a pharmaceutically acceptable salts, metabolites, isotopes, solvates or prodrugs thereof, wherein, Ra, Rb, Rc, Rd, R1, R2, L and Het-Ar are as defined herein. These compounds can be used for the preventive and / or therapeutic treatment of diseases or disorders associated with abnormal activities of nerve growth factor (NGF) receptor TrkA such as Pain, inflammation or an inflammatory diseases, Cancer, atherosclerosis, restenosis, thrombosis, Neurodegenerative diseases, Erectile Dysfunction (ED), Skin disorders, Autoimmune disease like Multiple sclerosis, Sj gren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis, Infectious diseases, diseases related to an imbalance of the regulation of bone remodeling, endometriosis, pelvic pain syndrome and diseases resulting from abnormal tissue remodelling and fibrotic disorders; or a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination.
Owner:GVK BIOSCI PTE LTD

Porous composite with graded bioabsorbability, artificial bone using the same, and manufacturing method thereof

The object of the present invention is to provide a calcium phosphate-collagen fiber composite which has an excellent mechanical property, can induce bone replacement by rapid bone remodeling, and can be used in a high-load region. The object can be solved by a porous composite comprising a calcium phosphate crystal and a collagen fiber at a weight ratio of 80:20 to 20:80, wherein (1) a bioabsorbability of the porous composite is graded, and (2) the density of the porous composite determined by gravimetric method is 300 to 1500 mg / cm3.
Owner:TOKYO INST OF TECH

Cell co-culture model for screening antiosteoporosis drugs and application of cell co-culture model

The invention belongs to the technical field of cell in-vitro culture, and relates to mesenchymal stem cells / osteoclast precursor cells / follicular cells co-culture model which is used for rapidly screening antiosteoporosis drugs. A co-culture system is characterized in that the mesenchymal stem cells and the osteoclast precursor cells are directly cultured in a contacting manner in a lower layer culture chamber in an upper and a lower layers of culture systems, the follicular cells are cultured on a semipermeable membrane of the upper layer culture chamber in an adherence manner: the culture system is used for simulating the bone remodeling process of bone tissues under an in-vitro condition; the cell co-culture model is used for rapidly screening the antiosteoporosis drugs according to the influence of the drugs on the release of alkaline phosphatase, tartrate-resistant acid phosphatase and estrogen.
Owner:DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI

1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor

Provided is Compound (I) or a pharmaceutically acceptable salt thereof, which is an inhibitor of TrkA kinase and is useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation and inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis, pelvic pain syndrome, diseases related to an imbalance of the regulation of bone remodeling, and diseases resulting from Connective Tissue Growth Factor aberrant signaling.
Owner:ARRAY BIOPHARMA

Pufa covered implants

A medical or dental implant which contains a metal material selected from the group consisting of titanium or an alloy thereof, wherein at least part of the surface of the metal material is coated with a layer of a polyunsaturated fatty acids (PUFA). In a preferred embodiment, the implant has been exposed to UV radiation for at least 30 seconds before, simultaneously with and / or after the coating with PUFA. Depending on the concentration of polyunsaturated fatty acids on the surface, at least parts of the implant exhibits improved effect on adhesion of mineralized and / or hard tissue, such as on bone remodeling and / or improved biocompatibility, or alternatively inhibits adhesion of mineralized and / or hard tissue to the implant. The metal material is preferably titanium, the polyunsaturated fatty acid is preferably EPA.
Owner:NUMAT BIOMEDICAL

Medicament for treating osteonecrosis

ActiveCN101327223AAvoid and address deficienciesAvoid neoplasiaSkeletal disorderMammal material medical ingredientsHuman bodyOsteoblast
The invention relates to a medicine for curing osteonecrosis, belonging to the field of regenerative medicine engineering. Human amniotic mesenchymal cells (hAMCs) are used as cell source for cellular transplantation and tissue organization so as to cure the osteonecrosis and to provide a new way for repairing a damaged osseous tissue and reorganizing tissues. Based on the multi-lineage differentiation potential of the hAMCs, osteocytes, osseous tissues and vascular endotheliums can be differentiated in the human body, thereby completing the processes of osteanagenesis, bone remodeling and vascularization and forming a new osseous tissue integrated with the tissues of the patient.
Owner:北京科润维德生物技术有限责任公司

Drug loading biological activity glass complex calcium phosphate bone cement and application thereof

The invention discloses drug loading biological activity glass complex calcium phosphate bone cement and application thereof. According to the invention, drug loading biological activity glass microspheres are added into the calcium phosphate bone cement, the in vivo degradation rate of the biological activity glass microspheres is relatively high, a porous structure inside the calcium phosphate bone cement can be adjusted, a bone-like apatite layer can be formed on the surface of each biological activity glass microsphere, and the drug loading biological activity glass complex calcium phosphate bone cement has good biological activity; and simultaneously, loaded drugs are released while the biological activity glass microspheres are degraded, so that the bone cement has the effects of bone remodeling and drug therapy; and the cell proliferation is promoted by using strontium-doped octacalcium phosphate modified alpha-TCP bone cement. The calcium phosphate bone cement has moderate timeof coagulation, is good in syringeability, mechanical strength and biocompatibility, and meets clinic requirements of bone repair.
Owner:GUANGZHOU RAINHOME PHARM&TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products